Effect of Testosterone Treatment on Volumetric Bone Density and Strength in Older Men With Low Testosterone: A Controlled Clinical Trial

Cited by (362)

Items 101–200 of 362

1. The state of testosterone therapy since the FDA's 2015 labelling changes: Indications and cardiovascular risk
   Martin M. Miner, Abraham Morgentaler, Mohit Khera, Abdulmaged M. Traish · 2018 · Clinical Endocrinology
2. Aging and Bone Metabolism
   Robert J. Pignolo · 2023 · Comprehensive physiology
3. Cross‐sex testosterone therapy modifies the renal morphology and function in female rats and might underlie increased systolic pressure
   Débora Conte Kimura, Rogério Argeri, Charlles Heldan de Moura Castro, Magnus Regios Dias-da-Silva, Guiomar Nascimento Gomes · 2021 · Clinical and Experimental Pharmacology and Physiology
4. The complex pathophysiology of bone fragility in obesity and type 2 diabetes mellitus: therapeutic targets to promote osteogenesis
   Siresha Bathina, Reina Armamento‐Villareal · 2023 · Frontiers in Endocrinology
5. Targeting Sclerostin in Postmenopausal Osteoporosis: Focus on Romosozumab and Blosozumab
   Ian R. Reid · 2017 · BioDrugs
6. Testosterone Replacement Therapy Has Limited Effect on Increasing Bone Mass Density in Older Men: a Meta-analysis
   Wang Junjie, Hao Dongsheng, Lei Sun, Hongzhuo Li, Changying Sun · 2019 · Current Pharmaceutical Design
7. Breaking News — Testosterone Treatment and Fractures in Older Men
   Mathis Grossmann, Bradley David Anawalt · 2024 · New England Journal of Medicine
8. Testosterone, Diabetes Risk, and Diabetes Prevention in Men
   Bu Beng Yeap, Gary Wittert · 2022 · Endocrinology and Metabolism Clinics of North America
9. Male Hypogonadism: A Review
   Marco Marcelli, Sanjay Navin Mediwala · 2020 · Journal of Investigative Medicine
10. Aging and Bone Metabolism
    Robert J. Pignolo · 2023 · Comprehensive physiology
11. Osteoporosis evaluation and treatment recommendations in rheumatoid arthritis
    Katherine D. Wysham, Joshua F. Baker, Radhika Rao Narla · 2022 · Best Practice & Research Clinical Rheumatology
12. Testosterone therapy in older men: clinical implications of recent landmark trials
    Mathis Grossmann, Bradley D. Anawalt, Bu Beng Yeap · 2024 · European Journal of Endocrinology
13. Testosterone and Dehydroepiandrosterone Treatment in Ageing Men: Are We All Set?
    Andreas Walther, Julian Seuffert · 2019 · The World Journal of Men s Health
14. Sex, Energy, Well-Being and Low Testosterone: An Exploratory Survey of U.S. Men’s Experiences on Prescription Testosterone
    Alex A. Straftis, Peter B. Gray · 2019 · International Journal of Environmental Research and Public Health
15. Factors associated with low bone density in opioid substitution therapy patients: a systematic review
    Ramli, Fitri Fareez, Syed Hashim, Syed Alhafiz, Mohd Effendy, Nadia · 2021 · International Journal of Medical Sciences
16. Testosterone replacement therapy: clinical considerations
    Patrick M. Luther, Noah J Spillers, Norris C Talbot, Evan S. Sinnathamby, Dakota Ellison, Rucha A. Kelkar, Shahab Ahmadzadeh, Sahar Shekoohi, Alan D. Kaye · 2024 · Expert Opinion on Pharmacotherapy
17. Proceedings of the 2018 Santa Fe Bone Symposium: Advances in the Management of Osteoporosis
    Edward Michael Lewiecki, John Paul Bilezikian, Lora Giangregorio, Susan L. Greenspan, Sundeep Khosla, Paul J. Kostenuik, Kelly Krohn, Michael R. McClung, Paul D. Miller, Roberto Pacifici · 2018 · Journal of Clinical Densitometry
18. Testosterone Replacement Therapy
    Cem Haymana, Alper Sönmez · 2022 · Management of urology
19. Associations of pregnancy phthalate concentrations and their mixture with early adolescent bone mineral content and density: The Health Outcomes and Measures of the Environment (HOME) study
    Jordan R. Kuiper, Joseph M. Braun, Antonia M. Calafat, Bruce Perrin Lanphear, Kim M. Cecil, Aimin Chen, Yingying Y. Xu, Kimberly A. Yolton, Heidi J. Kalkwarf, Jessie Poulin Buckley · 2021 · Bone
20. Testosterone therapy-induced erythrocytosis: can phlebotomy be justified?
    Peter Bond, Tijs Johannes Verdegaal, Diederik Laurens Smit · 2024 · Endocrine Connections
21. Increase in Osteocalcin Following Testosterone Therapy in Men With Type 2 Diabetes and Subnormal Free Testosterone
    Husam Ghanim, Sandeep Dhindsa, Kelly Green, Sanaa Abuaysheh, Manav Batra, Antoine Makdissi, Ajay Chaudhuri, Paresh Dandona · 2019 · Journal of the Endocrine Society
22. Testosterone treatment of late-onset hypogonadism – benefits and risks
    Peter J. Snyder · 2022 · Reviews in Endocrine and Metabolic Disorders
23. Testosterone replacement in men with age-related low testosterone: what did we learn from The Testosterone Trials?
    Alvin M. Matsumoto · 2019 · Current Opinion in Endocrine and Metabolic Research
24. Association between Serum Total Testosterone Level and Bone Mineral Density in Middle-Aged Postmenopausal Women
    Jinxiao Yang, Guofei Kong, Xiaocong Yao, Zhongxin Zhu · 2022 · International Journal of Endocrinology
25. The medicalization of testosterone: reinventing the elixir of life
    Thiago Gagliano‐Jucá, Mauricio Álvarez, Shehzad Sultan Basaria · 2022 · Reviews in Endocrine and Metabolic Disorders
26. Symptoms of Late-Onset Hypogonadism in Men
    Peter J. Snyder · 2022 · Endocrinology and Metabolism Clinics of North America
27. Validation of Biomechanical Computed Tomography for Fracture Risk Classification in Metastatic Hormone-sensitive Prostate Cancer
    John Kent Lin, Caleb M. Hearn, Emily J. Getzen, Qi Long, David C. Lee, Tony M. Keaveny, Ravishankar Jayadevappa, Kyle William Robinson, Yu-Ning Wong, Kara N. Maxwell et al. · 2023 · European Urology Oncology
28. Androgens as the “old age stick” in skeletal muscle
    Giulia Gentile, Ferdinando De Stefano, Carmela Sorrentino, Rosa D’Angiolo, Carmine Lauretta, Pia Giovannelli, Antimo Migliaccio, Gabriella Castoria, Marzia Di Donato · 2025 · Cell Communication and Signaling
29. Optimizing Diagnostic Accuracy and Treatment Decisions in Men With Testosterone Deficiency
    Shalender Bhasin, Noelle Ozimek · 2021 · Endocrine Practice
30. Association of total testosterone status with bone mineral density in adults aged 40–60 years
    Nan Wang, Lixiang Wang, Chengcheng Huang · 2021 · Journal of Orthopaedic Surgery and Research
31. Anabolic-Androgenic Steroids and Exercise Training: Breaking the Myths and Dealing With Better Outcome in Sarcopenia
    Hugo Falqueto, Marcelo Rodrigues dos Santos, Leandro Henrique Manfredi · 2022 · Frontiers in Physiology
32. Benefits and Risks of Testosterone Treatment of Older Men with Hypogonadism
    Francesca Galbiati, Anna L. Goldman, Arijeet K. Gattu, Ezgi Caliskan Guzelce, Shalender Bhasin · 2022 · Urologic Clinics of North America
33. Testosterone replacement therapy and the risk of adverse cardiovascular outcomes and mortality
    Kevin M. Pantalone, Joyce George, Xinge Ji, Michael W. Kattan, Alex Milinovich, Janine M. Bauman, Bartolome G. Burguera, Robert S. Zimmerman, Anita D. Misra‐Hebert · 2019 · Basic and Clinical Andrology
34. Early life organophosphate ester exposures and bone health at age 12 years: The Health Outcomes and Measures of the Environment (HOME) Study
    Jordan R. Kuiper, Ann M. Vuong, Bruce Perrin Lanphear, Antonia M. Calafat, María Ospina, Kim M. Cecil, Yingying Y. Xu, Kimberly A. Yolton, Heidi J. Kalkwarf, Joseph M. Braun et al. · 2022 · The Science of The Total Environment
35. Aging and sex hormones in males
    Maria Chiara Decaroli, Sara De Vincentis, Vincenzo Rochira · 2021 · Vitamins and hormones
36. Therapeutic effects of androgens for cachexia
    Luca Giovanelli, Richard Quinton · 2021 · Best Practice & Research Clinical Endocrinology & Metabolism
37. The Illusory Case for Treatment of an Invented Disease
    David J. Handelsman · 2022 · Frontiers in Endocrinology
38. Male Reproduction and Aging
    Maria Gabriela Figueiredo, Thiago Gagliano‐Jucá, Shehzad Sultan Basaria · 2023 · Endocrinology and Metabolism Clinics of North America
39. Roles of sex hormones in mediating the causal effect of vitamin D on osteoporosis: A two-step Mendelian randomization study
    Yongwei Du, Baohui Xie, Maoyuan Wang, Yan-Biao Zhong, Zhimai Lv, Yun Luo, Qiwei He, Zhen Liu · 2023 · Frontiers in Endocrinology
40. Hypopituitarism and bone disease: pathophysiology, diagnosis and treatment outcomes
    Amit Akirov, Yaron Rudman, Maria Fleseriu · 2024 · Pituitary
41. Associations of Serum Testosterone and SHBG With Incident Fractures in Middle-aged to Older Men
    Louise Grahnemo, Ross James Marriott, Kevin Murray, Lauren T Tyack, Maria Nethander, Alvin M. Matsumoto, ERIC S. ORWOLL, Dirk Vanderschueren, Bu Beng Yeap, Claes Ohlsson · 2024 · The Journal of Clinical Endocrinology & Metabolism
42. Benefits of Testosterone Hormone in the Human Body: A Systematic Review
    Julio G Rojas-Zambrano, Augusto R Rojas-Zambrano, Andres F Rojas-Zambrano, Gabriela E Barahona-Cueva · 2025 · Cureus
43. Trps1 targets Ccnd1 to regulate mouse Leydig cell proliferation
    Jiandong Sun, Hua Li, Chengyu Lv, Eman N. Draz, Yue Liu, Zihang Lin, Weitao Hu, Kaien Mo, Jianmin Lin, Weiwei Xu et al. · 2021 · Andrology
44. An autofluorescence-based isolation of Leydig cells for testosterone deficiency treatment
    Peng Luo, Xin Gang Feng, Ronghai Deng, Fulin Wang, Yadong Zhang, Xiangping Li, Min Zhang, Zi Wan, Andy Peng Xiang, Kai Xia et al. · 2021 · Molecular and Cellular Endocrinology
45. Androgens In Men Study (AIMS): protocol for meta-analyses of individual participant data investigating associations of androgens with health outcomes in men
    Bu Beng Yeap, Ross James Marriott, Robert Adams, Leen Antonio, Christie Mitchell Ballantyne, Shalender Bhasin, Peggy Mannen Cawthon, David J. Couper, Adrian Sandra Dobs, Leon A Flicker et al. · 2020 · BMJ Open
46. Reflections on the T Trials
    Ronald S. Swerdloff, Christina Wang · 2020 · Andrology
47. Pharmacologic Interventions for Fracture Risk Reduction in the Oldest Old: What Is the Evidence?
    Jad G. Sfeir, Robert J. Pignolo · 2021 · JBMR Plus
48. Adult Male Hypogonadism
    Bradley D. Anawalt, Kim O’Connor, Mathis Grossmann · 2026 · JAMA
49. Crosstalk between androgen receptor and protein kinase G signaling in bone: implications for osteoporosis therapy
    Hema Kalyanaraman, Shyamsundar Pal China, Darren E. Casteel, Renate B. Pilz · 2025 · Trends in Pharmacological Sciences
50. Testosterone Replacement Reduces Morbidity and Mortality for Most Patients With Cirrhosis
    Elliot B. Tapper, Xi Chen, Neehar D. Parikh · 2025 · Clinical Gastroenterology and Hepatology
51. Long-Term Cardiovascular Safety of Testosterone-Replacement Therapy in Middle-Aged and Older Men: A Meta-analysis of Randomized Controlled Trials
    Marcelo Antonio Pinheiro Braga, André Rivera, Gabriel Marinheiro, Nicole Santos Felix, Pedro E P Carvalho, Douglas Mesadri Gewehr, Larissa Teixeira, Mariana R.C. Clemente, Pedro Cotta Abrahão Reis, Lucas G. C. R. de Amorim et al. · 2025 · American Journal of Cardiovascular Drugs
52. Trials of testosterone replacement reporting cardiovascular adverse events
    Shehzad Sultan Basaria, Thiago Gagliano‐Jucá · 2018 · Asian Journal of Andrology
53. Testosterone and type 2 diabetes prevention: translational lessons from the T4DM study
    Gary Wittert, Mathis Grossmann, Bu Beng Yeap, David J. Handelsman · 2023 · Journal of Endocrinology
54. Peyronie’s disease and testosterone deficiency: Is there a link?
    Ishan Aditya, Ethan D. Grober, Yonah Krakowsky · 2019 · World Journal of Urology
55. Testosterone therapy in hypogonadal patients and the associated risks of cardiovascular events
    Zelal Jaber Kharaba, Manal Ali Buabeid, Nihal Abdalla Ibrahim, Feras Jirjees, Hala Jehad Al-Obaidi, Adnan Kaddaha, Laleh Khajehkarimoddini, Yassen Alfoteih · 2020 · Biomedicine & Pharmacotherapy
56. Testosterone Therapy for Prevention and Treatment of Obesity in Men
    Monica Caliber, Farid Saad · 2020 · Androgens Clinical Research and Therapeutics
57. Evaluation and Treatment of Male Hypogonadism
    Robert Michael Sargis, Andrew M. Davis · 2018 · JAMA
58. Risks of Serious Injury with Testosterone Treatment
    Christopher J. Yarnell, Deva Thiruchelvam, Donald A. Redelmeier · 2020 · The American Journal of Medicine
59. Effect of testosterone treatment on the trabecular bone score in older men with low serum testosterone
    Jane A. Cauley, Susan S. Ellenberg, Ann V. Schwartz, Kristine E. Ensrud, Tony M. Keaveny, Peter J. Snyder · 2021 · Osteoporosis International
60. Opioid-induced androgen deficiency (OPIAD): prevalence, consequence, and efficacy of testosterone replacement
    Kenneth Ho · 2019 · Current Opinion in Endocrine and Metabolic Research
61. Association of Serum Testosterone at 12 Years with a Subsequent Increase in Bone Mineral Apparent Density at 18 Years: A Longitudinal Study of Boys in Puberty
    Reeli Tamme, Jaak Jürimäe, Evelin Mäestu, Liina Remmel, Priit Purge, Eva Mengel, Vallo Tillmann · 2019 · Hormone Research in Paediatrics
62. Fine particulate matter and osteoporosis: evidence, mechanisms, and emerging perspectives
    Jiyang Zhang, Hanshu Chu, Ran Li, Cuiqing Liu · 2024 · Toxicological Sciences
63. Osteoporosis in Men: an Overlooked Patient Population
    Sharon Hsiao-Han Chou · 2025 · Current Osteoporosis Reports
64. Androgen Deprivation Therapy Differentially Impacts Bone and Muscle in the Short Term in Physically Active Men With Prostate Cancer
    Naim M. Maalouf, Avneesh B. Chhabra, Jason A. Zafereo, ROSS G. QUERRY, Dwight A. Towler, Uma J. Thakur, Joseph A. Frankl, JOHN R. POINDEXTER, Bayan Mogharrabi, May Xac et al. · 2021 · JBMR Plus
65. Public Health Need, Molecular Targets, and Opportunities for the Accelerated Development of Function-Promoting Therapies: Proceedings of a National Institute on Aging Workshop
    Rosaly Correa‐de‐Araujo, Shalender Bhasin · 2022 · The Journals of Gerontology Series A
66. Testosterone and aging male, a perspective from a developing country
    Bac Nguyen Hoai, Hoang Long, Nguyễn Cao Thắng, Quan Minh Pham, Emmanuele Angelo Jannini · 2023 · The Aging Male
67. Thromboembolism Peaking 3 Months after Starting Testosterone Therapy: Testosterone–Thrombophilia Interactions
    Charles J. Glueck, Naila Goldenberg, Ping Wang · 2017 · Journal of Investigative Medicine
68. Testosterontherapie im Alter bei Hypogonadismus und Komorbiditäten
    Michael Zitzmann · 2020 · Der Internist
69. The relationship between orthopedic clinical imaging and bone strength prediction
    He Gong, Meng Zhang, Shaowei Jia, Linwei Lv · 2021 · Medicine in Novel Technology and Devices
70. Hypogonadism is frequent in very old men with multimorbidity and is associated with anemia and sarcopenia
    Sabine Schluessel, Martin Bidlingmaier, Sebastian Martini, Martín Reincke, Nicole Reisch, Anna Schaupp, Günter Karl Stalla, Daniel Teupser, Ralf Schmidmaier, Michael Drey · 2023 · Zeitschrift für Gerontologie und Geriatrie
71. Impact of Testosterone on Male Health: A Systematic Review
    Julio G Rojas-Zambrano, Augusto R Rojas-Zambrano, Andres F Rojas-Zambrano · 2025 · Cureus
72. Toward Sex-Specific Biomaterials Innovation: A Perspective
    Koons, Gerry L. · 2025 · ACS Biomaterials Science & Engineering
73. The Effect of Exercise on Body Composition and Physical Performance in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy (ADT): A Narrative Synthesis
    Lucas Logan, Kellie L. Toohey, Phillip S. Kavanagh, Catherine C. Paterson, Andrew J. McKune · 2020 · Seminars in Oncology Nursing
74. Replacement with sex steroids in hypopituitary men and women: implications for gender differences in morbidities and mortality
    Darran Mc Donald, Tara McDonnell, Michael O’Reilly, Mark Sherlock · 2024 · Reviews in Endocrine and Metabolic Disorders
75. Osteoporosis in Men
    Robert A. Adler · 2009 · Humana Press eBooks
76. Osteosarcopenia: pathogenesis, diagnosis and therapeutic approaches
    Tatiana A. Grebennikova, Цориев Тимур Тамерланович, Juliya R Vorobeva, Zhanna E. Belaya · 2020 · Annals of the Russian academy of medical sciences
77. Hormone Replacement
    Bradley R. Williams, Janet Soojeung Cho · 2017 · Primary Care Clinics in Office Practice
78. Reproductive and Nonreproductive Actions of Testosterone
    Shalender Bhasin, Ravi Jasuja · 2018 · Elsevier eBooks
79. Short-Term Changes in Bone Metabolism Among Transgender Men Starting Gender-Affirming Hormone Therapy: A Systematic Review and Meta-analysis
    Daniele Tienforti, Lorenzo Marinelli, Jeroen Vervalcke, Luca Spagnolo, Federica Antolini, Andreina Bichiri, Marco Giorgio Baroni, Giovanna Motta, Guy G. T'Sjoen, Arcangelo Barbonetti · 2024 · Calcified Tissue International
80. Testosterone-induced erythrocytosis: addressing the challenge of metabolic syndrome and widely prescribed SGLT2-inhibitor drugs
    Federica Tramontana, Azmi Mohammed, Yaasir H. Mamoojee, Richard Quinton · 2025 · Endocrine Connections
81. Osteoporosis in men—East and West: Can the twain meet? A perspective from Asia
    Gerald Gui Ren Sng, Jean‐Yves Reginster, Majed Saleh Alokail, Manju Chandran · 2024 · Osteoporosis and Sarcopenia
82. What does the research say about androgen use and cerebrovascular events?
    M. Reza Sadaie, Mehdi Farhoudi, Masumeh Zamanlu, Naser Aghamohammadzadeh, Atieh Amouzegar, Robert E. Rosenbaum, Gary A. Thomas · 2018 · Therapeutic Advances in Drug Safety
83. The Relation Between Steroid Secretion Patterns and the Androgen Receptor Gene Polymorphism on Physical Health and Psychological Well-Being—Longitudinal Findings From the Men’s Health 40+ Study
    Tim Jonas Lacker, Andreas Walther, Serena Fiacco, Ulrike Ehlert · 2020 · Frontiers in Human Neuroscience
84. To T or not to T: Differences in Testosterone Use and Discontinuation by HIV Serostatus among Men who Have Sex with Men
    Sabina Haberlen, Lisa P. Jacobson, FJ Palella, Adrian Sandra Dobs, Michael W Plankey, JE Lake, Lawrence Kingsley, Ronald D. Stall, Wendy S. Post, Todd Tarquin Brown · 2018 · HIV Medicine
85. Comparative study of the effects of osteoprotegerin and testosterone on bone quality in male orchidectomised rats
    Marta Martín-Fernández, Francisco Garzón-Márquez, Díaz Curiel M, Iván Prieto‐Potín, Luis Álvarez, David Guede, José Ramón Caeiro-Rey, Concepción de la Piedra · 2018 · The Aging Male
86. 236th ENMC International Workshop Bone protective therapy in Duchenne muscular dystrophy: Determining the feasibility and standards of clinical trials Hoofddorp, The Netherlands, 1–3 June 2018
    Sze Choong Wong, Volker W. Straub, Leanne Marie Ward, Rosaline C. M. Quinlivan, J. Adachi, S. Faisal Ahmed, Meg Anderton, Francesca Broggi, Nicola J. Crabtree, Imelda J. M. de Groot et al. · 2019 · Neuromuscular Disorders
87. Testosterone Therapy for the Treatment of Age-Related Hypogonadism: Risks with Uncertain Benefits
    Christine P. Nguyen, Mark Hirsch, Suresh Kaul, Corinne M. Woods, Hylton V. Joffe · 2021 · Androgens Clinical Research and Therapeutics
88. Testosterone Replacement Therapy Is Not Associated with Greater Revision Rates in Reverse Total Shoulder Arthroplasty
    Romir P. Parmar, Austin M. Cronen, Clayton H. Hui, Michael William Stickels, Evan S. Lederman, Anup Ajit Shah · 2025 · Journal of Clinical Medicine
89. The impact of a selective androgen receptor modulator (RAD140) on frailty and underlying mechanisms in older male and female C57Bl/6 mice
    Stefan Heinze-Milne, Maddison L. Hodgins, Susan Ellen Howlett · 2025 · Mechanisms of Ageing and Development
90. Testosterone and male rejuvenation
    Sevann Helo, Peyton Thomas, Nicholas N. Tadros · 2019 · Panminerva Medica
91. Musculoskeletal and body composition response to high-dose testosterone with finasteride after chronic incomplete spinal cord injury—a randomized, double-blind, and placebo-controlled pilot study
    Dana M. Otzel, Larissa Nichols, Christine F. Conover, STEPHEN A. MARANGI, Jayachandra R. Kura, Dominic K. Iannaccone, David J. Clark, Chris M. Gregory, Christopher F. Sonntag, Anita Wokhlu et al. · 2024 · Frontiers in Neurology
92. Proceedings of the 2024 Santa Fe Bone Symposium: Update on the Management of Osteoporosis and Rare Bone Diseases
    Edward Michael Lewiecki, John Paul Bilezikian, Amanda Clark, Michael Terrence Collins, Deborah M. Kado, Joseph M. Lane, Bente Lomholt Langdahl, Michael R. McClung, Peter J. Snyder, Emily Margaret Stein · 2024 · Journal of Clinical Densitometry
93. Gonadopenia And Aging In Men
    Sandeep Dhindsa, Michael S. Irwig, Kathleen Louise Wyne · 2018 · Endocrine Practice
94. Low free testosterone is associated with increased mortality in frail surgical patients
    Fangyi Lin, Gordon Hong, Frances Y. Kwon, Farha Pirani, Salima S. Makhani, Mark A. Henry, Ian J. Cooke, Reza Nabavizadeh, Eric R. Midenberg, Akanksha Mehta et al. · 2021 · Surgery Open Science
95. Ageing male (part 2): Management of functional hypogonadism in older men, a patient-centric holistic approach.
    Frederick C. W. Wu · 2022 · Best practice & research. Clinical endocrinology & metabolism
96. Impact of testosterone therapy on bone turnover markers in obese males with type 2 diabetes and functional hypogonadism
    Kristina Groti Antonič · 2022 · The Aging Male
97. Transplantation of encapsulated human Leydig-like cells: A novel option for the treatment of testosterone deficiency
    Xin Gang Feng, Kai Xia, Qiong Ke, Rongda Deng, Jintao Zhuang, Zi Wan, Peng Luo, Fulin Wang, Zhijun Zang, Xiangzhou Sun et al. · 2020 · Molecular and Cellular Endocrinology
98. Testosterone therapy and bone quality in men with diabetes and hypogonadism: Study design and protocol
    Vittoria Russo, Georgia Colleluori, Rui Chen, Sanjay Navin Mediwala, Clifford Qualls, Michael A. K. Liebschner, Dennis Tan Villareal, Reina Armamento‐Villareal · 2021 · Contemporary Clinical Trials Communications
99. Increased Bone Mineral Density in Male Patients With Idiopathic Hypogonadotropic Hypogonadism Who Undergo Sex Hormone Therapy: Findings From Cross-Sectional and Longitudinal Studies
    Rui Zhang, Jiangfeng Mao, Xi Wang, Min Nie, Wanlu Ma, Wen Ji, Bingqing Yu, Qibin Huang, Xueyan Wu · 2021 · Endocrine Practice
100. Further Elucidation of the Potential Benefits of Testosterone Therapy in Older Men
     ERIC S. ORWOLL · 2017 · JAMA Internal Medicine